Oncology Biomarker Testing—Awareness, Drivers, and the Future

The field of oncology biomarker testing is growing rapidly. With so many new cancer treatments available requiring specific biomarkers for prescription, oncologists have plenty of new information to follow and many decisions to make when treating individual tumors.*

Oncology Biomarker Testing— Awareness, Drivers, and the Future includes perspectives from 100 oncologists on this emerging field.

Download the report to learn:

  • Thoughts on how oncologists learn about new biomarker tests
  • Views on what other education resources would be helpful
  • Perspectives on oncology biomarker test choice and how these decisions are made
  • Trends and changes in the kinds of tests being conducted, especially around tissue vs liquid testing in solid tumors

Please fill out the form below to access this content

This field is for validation purposes and should be left unchanged.

Related Resources

Why Diversity Matters to Patients

Why Diversity Matters to Patients

How does a diverse patient audience feel about representation among their own physicians? Is the diversity outlook improving among healthcare professionals? Find out in our latest report from the 2023 Pharma Market Research Conference. We examined: Satisfaction with...

read more
ASH 2022 Real-Time Round-Up

ASH 2022 Real-Time Round-Up

The 2022 Annual Meeting of the American Society of Hematology (ASH) took place in person from December 10th to the 13th. InCrowd wanted to learn from those Hematologists and Hematology-Oncologists who attended these two objectives: Explore which condition had the most...

read more